RxSight (NASDAQ:RXST – Get Free Report) and Tactile Systems Technology (NASDAQ:TCMD – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, risk and dividends.
Earnings and Valuation
This table compares RxSight and Tactile Systems Technology”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| RxSight | $134.48 million | 1.94 | -$38.94 million | ($1.13) | -5.54 |
| Tactile Systems Technology | $329.52 million | 2.02 | $19.09 million | $0.88 | 33.52 |
Volatility & Risk
RxSight has a beta of 1.13, suggesting that its share price is 13% more volatile than the S&P 500. Comparatively, Tactile Systems Technology has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500.
Analyst Recommendations
This is a breakdown of recent ratings and recommmendations for RxSight and Tactile Systems Technology, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| RxSight | 3 | 7 | 2 | 0 | 1.92 |
| Tactile Systems Technology | 0 | 2 | 4 | 0 | 2.67 |
RxSight currently has a consensus target price of $8.59, indicating a potential upside of 37.20%. Tactile Systems Technology has a consensus target price of $38.60, indicating a potential upside of 30.85%. Given RxSight’s higher probable upside, analysts plainly believe RxSight is more favorable than Tactile Systems Technology.
Profitability
This table compares RxSight and Tactile Systems Technology’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| RxSight | -36.80% | -17.35% | -14.70% |
| Tactile Systems Technology | 5.91% | 9.70% | 7.53% |
Institutional & Insider Ownership
78.8% of RxSight shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 10.1% of RxSight shares are held by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Summary
Tactile Systems Technology beats RxSight on 11 of the 14 factors compared between the two stocks.
About RxSight
RxSight, Inc., a commercial-stage medical device company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens, a special photosensitive material that changes shape and power. RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
About Tactile Systems Technology
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
Receive News & Ratings for RxSight Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RxSight and related companies with MarketBeat.com's FREE daily email newsletter.
